Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.55 is 49% below its 5-year average of 4.96, near the low end of its 5-year range (1.84–10.68).
As of the fiscal period ended Tuesday, June 30, 2026. 5.13% above its 12-month average of 2.42.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.55.
QUICK RATIO (ACID-TEST)
2.55
QUICK RATIO (ACID-TEST) AVG TTM
2.42
QUICK RATIO (ACID-TEST) AVG 3Y
3.42
QUICK RATIO (ACID-TEST) AVG 5Y
4.96
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+5.13%
CURRENT VS 3Y AVG
-25.56%
CURRENT VS 5Y AVG
-48.64%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-24.03%
vs the sector median at left
SOPHiA GENETICS S.A.
Market Cap
$619.15M
Quick Ratio (Acid-Test)
2.55
TTM Avg
2.42
3Y Avg
3.42
5Y Avg
4.96
Market Cap
$611.57M
Quick Ratio (Acid-Test)
31.45
TTM Avg
23.29
3Y Avg
26.88
5Y Avg
23.21
Market Cap
$632.16M
Quick Ratio (Acid-Test)
3.05
TTM Avg
5.21
3Y Avg
6.01
5Y Avg
5.25
Market Cap
$634.30M
Quick Ratio (Acid-Test)
5.12
TTM Avg
4.05
3Y Avg
4.17
5Y Avg
7.50
Market Cap
$638.20M
Quick Ratio (Acid-Test)
16.82
TTM Avg
9.46
3Y Avg
14.12
5Y Avg
14.05
Market Cap
$597.55M
Quick Ratio (Acid-Test)
6.06
TTM Avg
2.91
3Y Avg
9.30
5Y Avg
9.54
Market Cap
$596.01M
Quick Ratio (Acid-Test)
1.49
TTM Avg
1.44
3Y Avg
1.41
5Y Avg
1.41
Market Cap
$584.48M
Quick Ratio (Acid-Test)
6.18
TTM Avg
5.54
3Y Avg
6.26
5Y Avg
5.77
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SOPHiA GENETICS S.A. (SOPH) | $619.15M | 2.55 | 2.42 | 3.42 | 4.96 |
| Climb Bio, Inc. (CLYM)vs › | $611.57M | 31.45 | 23.29 | 26.88 | 23.21 |
| OmniAb, Inc. (OABI)vs › | $630.63M | 4.80 | 4.27 | 4.36 | 3.29 |
| Prime Medicine, Inc. (PRME)vs › | $632.16M | 3.05 | 5.21 | 6.01 | 5.25 |
| Zevra Therapeutics, Inc. (ZVRA)vs › | $634.30M | 5.12 | 4.05 | 4.17 | 7.50 |
| Aura Biosciences, Inc. (AURA)vs › | $638.20M | 16.82 | 9.46 | 14.12 | 14.05 |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $597.55M | 6.06 | 2.91 | 9.30 | 9.54 |
| AngioDynamics, Inc. (ANGO)vs › | $596.01M | 1.49 | 1.44 | 1.41 | 1.41 |
| Fulgent Genetics, Inc. (FLGT)vs › | $584.48M | 6.18 | 5.54 | 6.26 | 5.77 |
| OrthoPediatrics Corp. (KIDS)vs › | $583.31M | 2.17 | 3.09 | 3.48 | 3.24 |
Quick Ratio
2.55
Excludes inventory
Current Ratio
2.69
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.55 |
| 2026-03-31 | 1.90 |
| 2025-12-31 | 1.84 |
| 2025-09-30 | 2.62 |
| 2025-06-30 | 3.21 |
| 2025-03-31 | 2.94 |
| 2024-12-31 | 3.49 |
| 2024-09-30 | 3.59 |
| 2024-06-30 | 4.17 |
| 2024-03-31 | 3.94 |
| 2023-12-31 | 3.97 |
| 2023-09-30 | 5.12 |
| 2023-06-30 | 5.17 |
| 2023-03-31 | 6.07 |
| 2022-12-31 | 7.13 |
| 2022-09-30 | 7.21 |
| 2022-06-30 | 7.39 |
| 2022-03-31 | 8.46 |
| 2021-12-31 | 9.69 |
| 2021-09-30 | 10.68 |
| 2021-06-30 | 3.07 |
| 2021-03-31 | 4.21 |
| 2020-12-31 | 4.92 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
